Vitoc Vlad 的 Form 4 申報
MAIA Biotechnology, Inc.（MAIA），2023/3/2 申報
- 申報編號
- 0001127602-23-008066
- 申報時間
- 2023/3/2
- 交易日
- 2023/2/28-3/1
- 申報延遲
- 2 天
- 10b5-1 計畫
- 表單沒有這欄（2023 年以前）
這份申報列了 2 筆非衍生性交易。公開市場買進合計 $6,988.11。交易後 2 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Vitoc VladCIK 0001913257 | 董事、高階主管（執行長）、持股 10% 以上大股東 |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F1
The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan for Mr. Vitoc that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended.
表 I 有 2 筆交易的價格引用這則附註。
- F2
The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $4.43 to $4.50, inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the Issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.
表 I 有 1 筆交易的價格引用這則附註。
- F3
The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $4.43 to $4.50, inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the Issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.
表 I 有 1 筆交易的價格引用這則附註。